Literature DB >> 12694097

Long-term results of balloon dilation of benign bile duct strictures.

L Suman1, E M Civelli, G Cozzi, M Milella, R Meroni, R Vercelli, S Sala, A Severini.   

Abstract

PURPOSE: To evaluate the results of percutaneous balloon dilation of benign bile duct strictures in a series of patients with a long follow-up period.
MATERIAL AND METHODS: 56 patients with benign bile duct strictures underwent balloon catheter dilation. These patients had strictures of various origins: postsurgical, postlocal not surgical treatments, associated with gallstones, due to primary sclerosing cholangitis and to Mirizzi's syndrome. In 41 cases the diagnosis was made on the basis of radiological findings and history and in 15 cases on the basis of transluminal biopsy.
RESULTS: In 87.5% of cases the treatment was immediately successful. There were no early recurrences, but 7 (21%) recurrences were seen over 1 year after treatment; of these, 57% underwent another balloon dilation procedure with a positive long-term outcome.
CONCLUSION: The long-term success rate obtained in 72% of this series confirms that percutaneous bile duct dilation is a valid alternative to surgery without being burdened by complications; the procedure is also a valid alternative to the approach using endoscopic stents.

Entities:  

Mesh:

Year:  2003        PMID: 12694097     DOI: 10.1080/j.1600-0455.2003.00043.x

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.701


  2 in total

Review 1.  Current management of biliary strictures.

Authors:  Jennifer G Hall; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

2.  Long-term follow-up evaluation for more than 10 years after endoscopic treatment for postoperative bile duct strictures.

Authors:  Yasuhisa Kuroda; Toshio Tsuyuguchi; Yuji Sakai; Sudhamshu K C; Takeshi Ishihara; Taketo Yamaguchi; Hiromitsu Saisho; Osamu Yokosuka
Journal:  Surg Endosc       Date:  2010-04       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.